BRUKER CORPORATION Future Amortization Expense, Year Two (Deprecated 2012-01-31)
BRUKER CORPORATION (BRKR) reported Future Amortization Expense, Year Two (Deprecated 2012-01-31) of $19.80 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearTwo · last filed 2013-02-28
- BRUKER CORPORATION future amortization expense, year two (deprecated 2012-01-31) for fiscal 2012 was $19.80M, a 4.35% decline from fiscal 2011.
- BRUKER CORPORATION future amortization expense, year two (deprecated 2012-01-31) for fiscal 2011 was $20.70M.
| Period end | Future Amortization Expense, Year Two (Deprecated 2012-01-31) 12 month |
|---|---|
| 2012-12-31 | $19.80M 10-K · filed 2013-02-28 |
| 2011-12-31 | $20.70M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |